🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Postoperative High-flow Nasal Oxygenation After High-risk Surgery in the Frail Adult

RecruitingNAAges 18 Years - anyAllRegion Stockholm
NCT07464730 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

High flow nasal oxygen (HFNO) in the immediate postoperative period has been demonstrated to reduce the risk of postoperative pulmonary complications (PPC) after cardiothoracic surgery. In specific groups of patients such as the obese and after upper abdominal surgery the results are contradictive. However, there is lack of evidence if HFNO in the general high-risk patient after abdominal and non-cardiac thoracic surgery can reduce the prevalence of PPC, hypoxaemia and escalation of therapy. Therefore, the investigators aim to compare the use of HFNO with conventional oxygen therapy (COT) in high-risk patients after abdominal and non-cardiac thoracic surgery regarding postoperative pulmonary complications.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: Adults (≥18 years old) scheduled for elective abdominal (laparotomy or laparoscopy), open abdominal vascular or non-cardiac thoracic surgery under general anaesthesia with an estimated duration over 3 hours. AND Meeting at least two of the following criteria: * Age \> 65 years * BMI \>30 * Preoperative SpO2 \<95 % * Scheduled for lobectomy or pulmonary segment resection * Respiratory tract infection the last month * Preoperative anaemia (Hb \<100) or severe hypoalbuminemia (\<20 g/L) * Current smoker or previous smoker with \>30 packyears * Pulmonary disease or OSAS * Heart failure * Clinical frailty (CFS 4) Exclusion Criteria: * Not suitable for postoperative HFNO, as decided by a study member or the anaesthetist in charge (such as total nasal obstruction, skull fracture, facial injuries) * Pregnancy * Not able to understand the study information or sign an informed consent. * Not able to participate with the treatment postoperatively * Planned for delayed extubation in the intensive care * Preoperative non-invasive ventilation due to respiratory failure or a higher level of care than a regular ward
💊

What it tests

  • High Flow Oxygen
  • Oxygen
📍

Where

1 site
Karolinska University Hospital
Stockholm, Sweden
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy